Navigation Links
Omthera Pharmaceuticals, Inc. Announces Closing of Initial Public Offering
Date:4/16/2013

PRINCETON, N.J., April 16, 2013 /PRNewswire/ -- Omthera Pharmaceuticals, Inc., an emerging specialty pharmaceutical company focused on the development and commercialization of new therapies for abnormalities in blood lipids, referred to as dyslipidemia, today announced the closing of its previously-announced initial public offering of 8,000,000 shares of its common stock at $8.00 per share.  Omthera's common stock is listed on the NASDAQ Global Market under the trading symbol "OMTH". All shares of common stock were offered by Omthera Pharmaceuticals, Inc.

BofA Merrill Lynch, Barclays and Leerink Swann acted as joint book-running managers for the offering; Stifel and Piper Jaffray served as co-managers.

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on April 11, 2013.  The offering was made only by means of a prospectus, copies of which may be obtained from: BofA Merrill Lynch, 222 Broadway, New York, NY 10038, Attn: Prospectus Department, or via email, at dg.prospectus_requests@baml.com, from Barclays, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, by calling (888) 603-5847, or by emailing barclaysprospectus@broadridge.com, or from Leerink Swann, Attention: Syndicate Department, One Federal Street, 37th Floor, Boston, MA 02110, or by calling (800) 808-7525 ext. 4814.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or other jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such st
'/>"/>

SOURCE Omthera Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Omthera Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering
2. Omthera Pharmaceuticals Presents Data From Analysis Of EVOLVE Trial Showing That Epanova Lowers ApoC-III, A Key Predictor of Cardiovascular Risk
3. Omthera Pharmaceuticals Announces Invitation to Attend Presentation of the Complete Data Sets from its Phase 3 EVOLVE and ESPRIT Clinical Studies
4. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
5. Avion Pharmaceuticals, LLC., announces further expansion of their Womens Health Sales Team
6. Covis Pharmaceuticals, Inc Named US Distributor For Five Additional Products
7. Edison Pharmaceuticals, Inc. signs licensing agreement with Dainippon Sumitomo Pharma Co., Ltd. for development & commercialization of orphan mitochondrial and adult central nervous system disease drugs
8. Harwood Feffer LLP Announces Investigation of Spectrum Pharmaceuticals, Inc.
9. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Spectrum Pharmaceuticals, Inc.
10. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2012 Financial Results
11. Keryx Biopharmaceuticals, Inc. To Host Conference Call on Fourth Quarter and Year-End 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... , May 21, 2015  When ... along the side of his neck, he ... took a couple weeks off from weight ... go away.                               A ... 26, was referred to Michel Kliot, ...
(Date:5/21/2015)... ATLANTA , May 21, 2015  CryoLife, Inc. ... tissue processing company focused on cardiac and vascular surgery, ... a quarterly cash dividend for the second quarter 2015 ... quarterly cash dividend of $0.03 per share will be ... of record as of June 12, 2015.  The ex-dividend ...
(Date:5/21/2015)... 21. Mai 2015 Dipexium ... ein Unternehmen für Arzneimittel im fortgeschrittenen ... und Vermarktung von Locilex® (Pexiganan-Creme 0,8 %) ... eine wissenschaftliche Posterpräsentation an, welche das ... vorstellt, OneStep-1 und OneStep-2, in der ...
Breaking Medicine Technology:Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4CryoLife Announces Quarterly Cash Dividend for the Second Quarter 2015 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 3Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 4Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 5Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 6Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 7
... 6, 2012  Mylan Inc. (Nasdaq: MYL ) ... of two dermatological products from Valeant Pharmaceuticals. Mylan has ... Phosphate / Benzoyl Peroxide Gel, which is the generic ... manufactured and marketed the generic version of this product ...
... welcomes Michael Podany as Vice President of Sales, West USA ... Mr. Podany will be responsible for developing and managing sales ... Keith (GM, Director of Sales, USA). Mr. ... in creating, managing, and growing a new base of business ...
Cached Medicine Technology:Mylan Completes Acquisition of Two Limited-Competition Dermatological Products from Valeant 2Mylan Completes Acquisition of Two Limited-Competition Dermatological Products from Valeant 3Samsung Medison America Appoints Michael Podany as Vice President of Sales, West USA 2
(Date:5/24/2015)... EnviroLeather™ by LDI, a leader in ... classic, rugged leather grain with enhanced stain resistance ... ink, to be easily removed. The collection is ... healthcare, hospitality and education environments. , InkGard Plus ... developing products that are more sustainable, less toxic ...
(Date:5/24/2015)... (PRWEB) May 24, 2015 Indiana Fiber ... provider announces Midwest Telecom of America, Inc. (MTA) has ... According to Cory Childs, IFN Enterprise Sales Manager, fiber ... providers. “IFN’s fiber transport provides MTA with the ... to their Tier 1 Internet and voice carriers located ...
(Date:5/24/2015)... (PRWEB) May 24, 2015 A ... indicator that the single best option for avoiding cardiovascular ... that fitness level was the single most powerful predictor ... variables such as diabetes and family history of premature ... maintaining lifelong heart and lung fitness. , The Importance ...
(Date:5/23/2015)... 2015 Dr. David Benvenuti, an experienced plastic ... a new article to his website that takes ... Benvenuti explained in the fascinating blog, he has recently ... earlobes. , Known as “gauging,” the technique involves placing larger ... Benvenuti said will eventually stretch the holes out to incredible ...
(Date:5/23/2015)... CO (PRWEB) May 23, 2015 On May ... in MuckFest. The event was a 5k mud obstacle run ... more than 2 million people worldwide, and the reason we ... community,” said Chad Davis, owner of Farrell’s eXtreme Bodyshaping. “One-hundred ... Multiple Sclerosis Society.” , The event was not only attended ...
Breaking Medicine News(10 mins):Health News:EnviroLeather By LDI Launches "InkGard Plus" - Stain Resistant Faux Leather 2Health News:Indiana Fiber Network, LLC Enables Midwest Telecom of America with Fiber Route Diversity 2Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 2Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 3Health News:Dr. Benvenuti, a Plastic Surgeon in Newport Beach, CA, Posts New Article about Repairing Ear Gauges 2Health News:Farrell’s eXtreme Bodyshaping Team Runs through the Muck for MS 2
... WAYNE, Pa., Sept. 28 Escalon Medical Corp.,(Nasdaq: ... quarter and,twelve months ended June 30, 2007. For ... increased,to $38,837,780 compared with $29,790,698 in fiscal 2006. This ... million lump sum settlement payment,from IntraLase Corp. to the ...
... Sanarus Medical today announced a,partnership with leading ... These Centers, including breast care physicians from,Connecticut to ... the awareness and availability of an innovative, non-surgical,treatment ... as,fibroadenomas. Sanarus will host a gathering of these ...
... she is giving a,keynote address or visiting on the ... and possibility. "Only in America could someone like ... warm laugh, "I,m a physically disabled woman whose,father is ... temples,and I,m running for Town Council as a Republican." ...
... pressure to combat,childhood obesity, the market for licensed foods ... breaking the $1,billion mark in 2011, according to Kids, ... from market research publisher Packaged Facts. Between 2002 ... and,beverage products rose 9%, from $684 million to $746 ...
... A 6-month diet restored normal blood pressure, study finds , , ... identified overweight as a direct cause of high blood pressure. ... people can bring down blood pressure to healthy levels by ... achieved before the borderline to outright obesity is crossed, said ...
... Blue Cross Blue Shield of Michigan is,partnering with ... in,five Michigan cities to help enroll eligible uninsured children ... to urge community leaders and small,business owners to help ... Attendees will be asked to send their staffs to ...
Cached Medicine News:Health News:Escalon(R) Reports Financial Results for 2007 Fiscal Year 2Health News:Escalon(R) Reports Financial Results for 2007 Fiscal Year 3Health News:Escalon(R) Reports Financial Results for 2007 Fiscal Year 4Health News:Escalon(R) Reports Financial Results for 2007 Fiscal Year 5Health News:Escalon(R) Reports Financial Results for 2007 Fiscal Year 6Health News:Escalon(R) Reports Financial Results for 2007 Fiscal Year 7Health News:Sanarus Announces Partnership With Leading US Breast Care Physicians for the Next Generation Visica 2(TM) Treatment System for Fibroadenomas 2Health News:Humor and Hope Sustain NJ Woman Through Disabling Movement Disorder, Election Campaign 2Health News:Pressure to Promote Healthier Eating to Cause Minor Growing Pains for Kids' Licensed Foods and Beverages 2Health News:Weight Loss Can Control Hypertension 2Health News:Weight Loss Can Control Hypertension 3Health News:Blue Cross Blue Shield of Michigan Launches Effort in Five Michigan Cities with Department of Community Health to Enroll Uninsured Children in MIChild 2
... is engineered to distribute contact pressure evenly over ... back, to maximize stability and patient comfort. ... readily conformable to patient anatomy, to provide a ... wool liner is standard on both units, as ...
An indirect immunofluorescence antibody test for the qualitative and semi-quantitative detection of endomysial antibodies (EMA) in human serum as an aid in the diagnosis of celiac disease and dermati...
Optical Urethrotome for Telescope 2.7 mm for children....
ACMI urethrotomes are available in two distinct styles to meet your specific professional needs. The Classic Series™ Otis Urethrotome consists of a blade, straight tip, and ball tip, with an av...
Medicine Products: